Literature DB >> 19034669

Calpain and proteasomal regulation of antiretroviral zinc finger protein OTK18 in human macrophages: visualization in live cells by intramolecular FRET.

Lindsey B Martinez1, Shannon M Walsh, Michael T Jacobsen, Shinji Sato, Jayme Wiederin, Pawel Ciborowski, Tsuneya Ikezu.   

Abstract

As part of the innate immune defense against HIV infection, OTK18, a zinc finger protein, is upregulated in human macrophages and reduces viral replication through suppression of viral long-terminal repeat promoter activity. Although we know that the processing products of OTK18 accumulate in the cytoplasm of brain perivascular macrophages in advanced HIV encephalitis cases, the molecular mechanisms behind its post-translational processing are still poorly understood. To characterize OTK18 processing, we assessed a panel of protease inhibitors to identify the candidates involved in the OTK18 processing using human monocyte-derived macrophages (MDM) overexpressing OTK18 by recombinant adenoviral gene transfer. Viral infection of MDM strongly increased the processing of OTK18 into its N-terminal fragment. Treatment of OTK18-expressing MDM with calpain and proteasome inhibitors significantly accumulated either full-length or processed OTK18 fragments in time- and dose-dependent manners. A series of OTK18 truncation mutants and synthetic peptides were tested to locate the calpain cleavage sites after arginine 359. Finally, we developed an enhanced cyan and yellow fluorescent protein (ECFP and EYFP)-based intramolecular fluorescent resonance energy transfer (intramolecular FRET) system to monitor the OTK18 endoproteolysis in human microglia cell line. Inhibition of proteasome activity significantly increased the intramolecular FRET signal in the nucleus. These data suggest that calpain and proteasome are involved in OTK18 endoproteolysis and degradation. Additionally, intramolecular FRET has proven to be a useful tool for monitoring the processing in live cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19034669      PMCID: PMC2644346          DOI: 10.1007/s11481-008-9140-4

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   4.147


  32 in total

1.  Regulation of LFA-1 activity through cytoskeleton remodeling and signaling components modulates the efficiency of HIV type-1 entry in activated CD4+ T lymphocytes.

Authors:  Mélanie R Tardif; Michel J Tremblay
Journal:  J Immunol       Date:  2005-07-15       Impact factor: 5.422

2.  Interleukin-10 inhibits HIV-1 LTR-directed gene expression in human macrophages through the induction of cyclin T1 proteolysis.

Authors:  Yan Wang; Andrew P Rice
Journal:  Virology       Date:  2006-06-15       Impact factor: 3.616

3.  OTK18, a zinc-finger protein, regulates human immunodeficiency virus type 1 long terminal repeat through two distinct regulatory regions.

Authors:  Masahide Horiba; Lindsey B Martinez; James L Buescher; Shinji Sato; Jenae Limoges; Yunquan Jiang; Clinton Jones; Tsuneya Ikezu
Journal:  J Gen Virol       Date:  2007-01       Impact factor: 3.891

4.  Establishment of human microglial cell lines after transfection of primary cultures of embryonic microglial cells with the SV40 large T antigen.

Authors:  N Janabi; S Peudenier; B Héron; K H Ng; M Tardieu
Journal:  Neurosci Lett       Date:  1995-08-04       Impact factor: 3.046

Review 5.  The calpain family and human disease.

Authors:  Y Huang; K K Wang
Journal:  Trends Mol Med       Date:  2001-08       Impact factor: 11.951

6.  Molecular cloning of CD68, a human macrophage marker related to lysosomal glycoproteins.

Authors:  C L Holness; D L Simmons
Journal:  Blood       Date:  1993-03-15       Impact factor: 22.113

7.  Human immunodeficiency virus type 1 gp120-mediated disruption of tight junction proteins by induction of proteasome-mediated degradation of zonula occludens-1 and -2 in human brain microvascular endothelial cells.

Authors:  Shinichi Nakamuta; Hiroshi Endo; Youichiro Higashi; Aoi Kousaka; Hiroshi Yamada; Mihiro Yano; Hiroshi Kido
Journal:  J Neurovirol       Date:  2008-05       Impact factor: 2.643

8.  Mechanisms for the inhibition of HIV replication by interferons-alpha, -beta, and -gamma in primary human macrophages.

Authors:  P R Meylan; J C Guatelli; J R Munis; D D Richman; R S Kornbluth
Journal:  Virology       Date:  1993-03       Impact factor: 3.616

9.  Induction of APOBEC3 family proteins, a defensive maneuver underlying interferon-induced anti-HIV-1 activity.

Authors:  Gang Peng; Ke Jian Lei; Wenwen Jin; Teresa Greenwell-Wild; Sharon M Wahl
Journal:  J Exp Med       Date:  2006-01-17       Impact factor: 14.307

10.  Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes.

Authors:  H E Gendelman; J M Orenstein; M A Martin; C Ferrua; R Mitra; T Phipps; L A Wahl; H C Lane; A S Fauci; D S Burke
Journal:  J Exp Med       Date:  1988-04-01       Impact factor: 14.307

View more
  2 in total

1.  Epithelial chemokine CXCL14 synergizes with CXCL12 via allosteric modulation of CXCR4.

Authors:  Paul J Collins; Michelle L McCully; Laura Martínez-Muñoz; César Santiago; James Wheeldon; Stephan Caucheteux; Sylvia Thelen; Valentina Cecchinato; Julia M Laufer; Vladimir Purvanov; Yoan R Monneau; Hugues Lortat-Jacob; Daniel F Legler; Mariagrazia Uguccioni; Marcus Thelen; Vincent Piguet; Mario Mellado; Bernhard Moser
Journal:  FASEB J       Date:  2017-03-30       Impact factor: 5.191

2.  Tau-tubulin kinase 1 and amyloid-β peptide induce phosphorylation of collapsin response mediator protein-2 and enhance neurite degeneration in Alzheimer disease mouse models.

Authors:  Seiko Ikezu; Kaitlin L Ingraham Dixie; Lacin Koro; Takashi Watanabe; Kozo Kaibuchi; Tsuneya Ikezu
Journal:  Acta Neuropathol Commun       Date:  2020-02-04       Impact factor: 7.801

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.